Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins
- PMID: 7666549
- PMCID: PMC189549
- DOI: 10.1128/JVI.69.10.6479-6486.1995
Classical swine fever virus: independent induction of protective immunity by two structural glycoproteins
Abstract
To study which proteins of classical swine fever virus (CSFV) are able to confer protective immunity in swine, N-terminal autoprotease, viral core protein, and the three structural glycoproteins were expressed via vaccinia virus recombinants (VVR). CSFV proteins synthesized in cells infected with VVR showed migration characteristics on sodium dodecyl sulfate gels identical to those of their respective CSFV counterparts. Apparently authentic dimerization of the recombinant glycoproteins was observed. The glycoproteins E0 and E2 were detected on the surfaces of VVR-infected cells. In protection experiments, swine were immunized with the different VVR, and the generation of humoral immune response was monitored. Only animals vaccinated with VVR expressing E0 and/or E2 resisted a lethal challenge infection with CSFV. Glycoprotein E0 represents a second determinant for the induction of protective immunity against classical swine fever.
Similar articles
-
Generation and immunogenicity analysis of recombinant classical swine fever virus glycoprotein E2 and Erns expressed in baculovirus expression system.Virol J. 2021 Feb 24;18(1):44. doi: 10.1186/s12985-021-01507-1. Virol J. 2021. PMID: 33627167 Free PMC article.
-
A Promising Trigene Recombinant Human Adenovirus Vaccine Against Classical Swine Fever Virus.Viral Immunol. 2016 May;29(4):244-51. doi: 10.1089/vim.2015.0068. Epub 2016 Feb 26. Viral Immunol. 2016. PMID: 26918463
-
Oronasal vaccination with classical swine fever virus (CSFV) replicon particles with either partial or complete deletion of the E2 gene induces partial protection against lethal challenge with highly virulent CSFV.Vaccine. 2005 May 9;23(25):3318-28. doi: 10.1016/j.vaccine.2005.01.076. Vaccine. 2005. PMID: 15837238
-
Laboratory diagnosis, epizootiology, and efficacy of marker vaccines in classical swine fever: a review.Vet Q. 2000 Oct;22(4):182-8. doi: 10.1080/01652176.2000.9695054. Vet Q. 2000. PMID: 11087126 Review.
-
The challenges of classical swine fever control: modified live and E2 subunit vaccines.Virus Res. 2014 Jan 22;179:1-11. doi: 10.1016/j.virusres.2013.10.025. Epub 2013 Nov 6. Virus Res. 2014. PMID: 24211665 Review.
Cited by
-
Comparison of antibody values in sera of pigs vaccinated with a subunit or an attenuated vaccine against classical swine fever.Vet Res Commun. 2003 May;27(4):329-39. doi: 10.1023/a:1024040326550. Vet Res Commun. 2003. PMID: 12872833 Clinical Trial.
-
Autophagy enhances the replication of classical swine fever virus in vitro.Autophagy. 2014 Jan;10(1):93-110. doi: 10.4161/auto.26843. Epub 2013 Nov 14. Autophagy. 2014. PMID: 24262968 Free PMC article.
-
Nucleotide sequence of classical swine fever virus strain Alfort/187 and transcription of infectious RNA from stably cloned full-length cDNA.J Virol. 1996 Jun;70(6):3478-87. doi: 10.1128/JVI.70.6.3478-3487.1996. J Virol. 1996. PMID: 8648680 Free PMC article.
-
Downstream Sequences Control the Processing of the Pestivirus Erns-E1 Precursor.J Virol. 2020 Dec 9;95(1):e01905-20. doi: 10.1128/JVI.01905-20. Print 2020 Dec 9. J Virol. 2020. PMID: 33028718 Free PMC article.
-
The carboxy-terminal sequence of the pestivirus glycoprotein E(rns) represents an unusual type of membrane anchor.J Virol. 2005 Sep;79(18):11901-13. doi: 10.1128/JVI.79.18.11901-11913.2005. J Virol. 2005. PMID: 16140766 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources